Molecular Structure:

Product description: Xylooligosaccharide is also hardly to be utilized by harmful microorganisms in intestine. Therefore, XOS can reach the end of small intestine and large intestine. XOS provides the nutrients for the beneficial microorganisms such as bifidobacteria, and selectively stimulate their growth. Furthermore, XOS candecrease the activity of enteric putrefactive and pathogenic intestinal bacteria. The beneficial microorganisms such as bifidobacteria may produce antimicrobial substances and decrease the secretion of endotoxin. As a bind receptor of pathogenic bacteria, Xylooligosaccharide may bind to plant agglutininglycoproteinon pathogenic bacteria cell surface, thus reducing the chance to bind to the digestive tract epithelia. This indicates that the pathogenic bacteria could not proliferate for the lack of nutrition from the host and hunger to death or loss the pathogenic ability. As the barrier, XOS can prevent the attachment of pathogenic bacteria with host cell, decrease antibiotics tolerance of these dissociated pathogenic bacteria, and meanwhile enhance the effect of antibiotics on sterilizing and restraining bacteria. Furthermore, they can bind to toxin, virus and eukaryote surfaces.